Brief: Cell Impact Gets Order Worth SEK 1.3 Mln From Nowogen Technology In China

Cell Impact AB (publ)

16/03/2021 06:46

March 16 (Reuters) - Cell Impact AB  CIb.ST :
    * SAID ON MONDAY HAS RECEIVED AN ORDER WORTH MSEK 1.3 FOR
SERIAL
PRODUCTION OF BIPOLAR FLOW PLATES FROM BEIJING-BASED NOWOGEN
TECHNOLOGY IN CHINA
    * THE ORDER IS A CONTINUATION OF THE PROTOTYPE ORDER THAT
NOWOGEN
PLACED IN SEPTEMBER LAST YEAR

    
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nBQN7JBpgl
    
 Further company coverage:  CIb.ST  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))